Wilson Sonsini Goodrich & Rosati advised Invus, F-Prime, and MedTech Venture Partners on the transaction. Zenflow, Inc., a medical device company developing a minimally invasive treatment...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Lexicon Pharmaceuticals, while Simpson Thacher represented Invus on the deal. Cooley represented the underwriters for the public offering. Lexicon Pharmaceuticals, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented Invus on the deal. Lexicon has agreed to sell 17,156,400 shares of its Common Stock to raise gross proceeds of approximately $42.9 million...
You must be a Standard 1 Year member to access this content.
